nitric oxide NO delivery

GeNO Obtains a Clearance for Its Inhaled NO Delivery System, GeNOsyl MV-1000, From FDA
Dec 14, 2012
GeNO has obtained a clearance for its inhaled nitric oxide (NO) delivery system, GeNOsyl MV-1000, from the US Food and Drug Administration (FDA). GeNOsyl MV-1000 system, which incorporates a primary delivery system, a backup system, ...

Tags: FDA, inhaled nitric oxide delivery system, clinical product, GeNO